Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,870
Total Claims
$1.3M
Drug Cost
520
Beneficiaries
$2,526
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-57%
Opioid rate vs peers
1.6% vs 3.8% avg
+115%
Cost per patient vs peers
$2,526 vs $1,174 avg
+79%
Brand preference vs peers
15.9% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.6%
Opioid Rate
161
Opioid Claims
$1,679
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,554 claims · $1.1M
Generic: 8,247 claims · $196K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tirzepatide | 107 | $131K |
| Empagliflozin | 134 | $129K |
| Semaglutide | 101 | $111K |
| Dulaglutide | 83 | $105K |
| Apixaban | 66 | $71K |
| Sitagliptin Phosphate | 64 | $64K |
| Fluticasone/Umeclidin/Vilanter | 46 | $62K |
| Dapagliflozin Propanediol | 50 | $61K |
| Rivaroxaban | 34 | $28K |
| Insulin Degludec | 35 | $26K |
| Insulin Detemir | 32 | $21K |
| Budesonide/Glycopyr/Formoterol | 18 | $17K |
| Budesonide/Formoterol Fumarate | 22 | $16K |
| Fluticasone Propion/Salmeterol | 23 | $14K |
| Exenatide Microspheres | 14 | $12K |
Prescribing Profile
Patient Profile
73
Avg Age
51%
Female
1.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About